2009•Huaxi yixueRequires access

The Clinical Effectiveness Of Low Dose Thalidomide Combined With Dexamethasone On Multiple Myeloma

Kou La

Open publisher page 0 citations

Abstract

Objective: To observe the effectiveness of low dose thalidomide combined with dexamethasone(LD-TD) on patients with multiple myeloma(MM).Methods: 18 cases with MM were enrolled for studies.Among them,10 case are initial treament and 8 cases are relapsed or/and refractory patients.The initial dosage of thalidomide was100 mg·d-1 with a increasing in 50 mg·d-1 weekly and the maximum dosage was 200 mg·d-1.At the same time,the administerd dosage of dexamethasone was 10 mg·d-1 for 4 days every month.Results: Among the 18 evaluable patients,3 of them achieved complete remission(CR),6 of them achieved partial remission(PR),7 of them showed partial improving and 2 of them had no effects.Side effects could been tolerate.Conclusion: LD-TD might be effective in these patients with relapsed or/and refractory MM,as well as these patients with initial treatment MM.

About this research paper

What this paper is about

Objective: To observe the effectiveness of low dose thalidomide combined with dexamethasone(LD-TD) on patients with multiple myeloma(MM).Methods: 18 cases with MM were enrolled for studies.Among them,10 case are initial treament and 8 cases are relapsed or/and refractory patients.The initial dosage of thalidomide was100 mg·d-1 with a increasing in 50 mg·d-1 weekly and the maximum dosage was 200 mg·d-1.At the same time,the administerd dosage of dexamethasone was 10 mg·d-1 for 4 days every month.Results: Among the 18 evaluable patients,3 of them achieved complete remission(CR),6 of them achieved partial remission(PR),7 of them showed partial improving and 2 of them had no effects.Side effects could been tolerate.Conclusion: LD-TD might be effective in these patients with relapsed or/and refractory MM,as well as these patients with initial treatment MM.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To observe the effectiveness of low dose thalidomide combined with dexamethasone(LD-TD) on patients with multiple myeloma(MM).Methods: 18 cases with MM were enrolled for studies.Among them,10 case are initial treament and 8 cases are relapsed or/and refractory patients.The initial dosage of thalidomide was100 mg·d-1 with a increasing in 50 mg·d-1 weekly and the maximum dosage was 200 mg·d-1.At the same time,the administerd dosage of dexamethasone was 10 mg·d-1 for 4 days every month.Results: Among the 18 evaluable patients,3 of them achieved complete remission(CR),6 of them achieved partial remission(PR),7 of them showed partial improving and 2 of them had no effects.Side effects could been tolerate.Conclusion: LD-TD might be effective in these patients with relapsed or/and refractory MM,as well as these patients with initial treatment MM.

Key concepts: Medicine, Thalidomide, Dexamethasone, Refractory (planetary science), Multiple myeloma, Internal medicine, Gastroenterology, Complete remission

Related papers

Back to paper searchBrowse research topicsOriginal source
The Clinical Effectiveness Of Low Dose Thalidomide Combined With Dexamethasone On Multiple Myeloma — Research Paper | ScholarLens